CIM Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$842K Sell
2,392
-11
-0.5% -$3.92K 0.22% 74
2025
Q4
$787K Hold
2,403
0.21% 83
2025
Q3
$678K Sell
2,403
-2,461
-51% -$714K 0.18% 93
2025
Q2
$1.31M Buy
4,864
+2,428
+100% +$688K 0.25% 83
2025
Q1
$759K Sell
2,436
-2
-0.1% -$591 0.17% 82
2024
Q4
$635K Sell
2,438
-12
-0.5% -$3.56K 0.19% 96
2024
Q3
$789K Sell
2,450
-71
-3% -$23.2K 0.23% 83
2024
Q2
$788K Sell
2,521
-24
-0.9% -$7.05K 0.24% 83
2024
Q1
$724K Hold
2,545
0.22% 94
2023
Q4
$733K Hold
2,545
0.24% 86
2023
Q3
$684K Sell
2,545
-55
-2% -$13.7K 0.25% 86
2023
Q2
$577K Buy
2,600
+6
+0.2% +$1.39K 0.2% 110
2023
Q1
$627K Buy
2,594
+116
+5% +$28.5K 0.23% 95
2022
Q4
$651K Sell
2,478
-66
-3% -$17.7K 0.26% 81
2022
Q3
$573K Hold
2,544
0.25% 83
2022
Q2
$619K Sell
2,544
-13
-0.5% -$3.19K 0.26% 85
2022
Q1
$618K Sell
2,557
-2
-0.1% -$460 0.21% 101
2021
Q4
$576K Sell
2,559
-46
-2% -$9.71K 0.17% 127
2021
Q3
$554K Sell
2,605
-14
-0.5% -$3.22K 0.17% 124
2021
Q2
$638K Sell
2,619
-61
-2% -$15K 0.2% 110
2021
Q1
$667K Sell
2,680
-93
-3% -$22.2K 0.21% 95
2020
Q4
$638K Sell
2,773
-41
-1% -$9.45K 0.21% 97
2020
Q3
$715K Sell
2,814
-28
-1% -$6.94K 0.27% 72
2020
Q2
$670K Hold
2,842
0.27% 79
2020
Q1
$576K Buy
2,842
+93
+3% +$20.3K 0.28% 75
2019
Q4
$663K Hold
2,749
0.26% 94
2019
Q3
$532K Sell
2,749
-3,307
-55% -$635K 0.2% 117
2019
Q2
$1.12M Buy
6,056
+223
+4% +$39.9K 0.41% 40
2019
Q1
$1.11M Buy
5,833
+2,394
+70% +$457K 0.43% 32
2018
Q4
$669K Sell
3,439
-3,715
-52% -$725K 0.29% 68
2018
Q3
$1.48M Sell
7,154
-3
-0% -$591 0.53% 18
2018
Q2
$1.32M Sell
7,157
-204
-3% -$36.1K 0.46% 26
2018
Q1
$1.25M Sell
7,361
-184
-2% -$33.8K 0.43% 30
2017
Q4
$1.31M Sell
7,545
-114
-1% -$20.2K 0.45% 32
2017
Q3
$1.43M Sell
7,659
-438
-5% -$77.6K 0.52% 28
2017
Q2
$1.4M Sell
8,097
-129
-2% -$21K 0.5% 32
2017
Q1
$1.35M Sell
8,226
-780
-9% -$130K 0.46% 34
2016
Q4
$1.32M Buy
9,006
+103
+1% +$15.5K 0.48% 35
2016
Q3
$1.49M Sell
8,903
-700
-7% -$118K 0.57% 25
2016
Q2
$1.46M Sell
9,603
-420
-4% -$65.3K 0.61% 29
2016
Q1
$1.5M Sell
10,023
-1,118
-10% -$166K 0.65% 25
2015
Q4
$1.81M Hold
11,141
0.83% 24
2015
Q3
$1.54M Hold
11,141
0.74% 29
2015
Q2
$1.71M Sell
11,141
-44
-0.4% -$7.05K 0.75% 26
2015
Q1
$1.79M Hold
11,185
0.78% 21
2014
Q4
$1.78M Hold
11,185
0.82% 26
2014
Q3
$1.57M Sell
11,185
-537
-5% -$70.1K 0.8% 27
2014
Q2
$1.39M Sell
11,722
-320
-3% -$37K 0.7% 37
2014
Q1
$1.49M Sell
12,042
-290
-2% -$35.2K 0.68% 32
2013
Q4
$1.41M Buy
12,332
+800
+7% +$91K 0.72% 42
2013
Q3
$1.29M Hold
11,532
0.76% 44
2013
Q2
$1.14M Buy
+11,532
New +$1.2M 0.68% 49

Other funds holding AMGN

CIM Investment Management's AMGN Position: Q1 2026 in Review

CIM Investment Management reduced its Amgen (AMGN) stake by 0.46% in Q1 2026, selling an estimated $3.92K and leaving 2,392 shares worth $842K. The position accounts for 0.22% of the portfolio, ranked #74.

CIM Investment Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.81M in Q4 2015. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • CIM Investment Management held 2,392 shares of Amgen worth $842K as of Q1 2026.
  • CIM Investment Management sold 11 Amgen shares in Q1 2026, an estimated $3.92K.
  • Amgen made up 0.22% of CIM Investment Management's portfolio in Q1 2026, its #74 holding.
  • CIM Investment Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • CIM Investment Management's Amgen position peaked at $1.81M in Q4 2015.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.